BackPulmonx Overview
Pulmonx Corp

Pulmonx Target Price

See Pulmonx's analyst price targets ($5) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.98

Average Target Price

$5.0067.8% upside

1 analysts in the last 4 months

High: $5 | Low: $5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-10-28Canaccord GenuityJohn Young$567.8% upsideOpen
2025-10-28Lake Street$434.2% upsideOpen
2025-07-31Piper SandlerJason Bednar$2.516.1% downsideOpen
2024-10-31Piper SandlerJason Bednar$10235.6% upsideOpen
2024-08-01Canaccord GenuityWilliam Plovanic$16436.9% upsideOpen
2024-06-04Loop Capital MarketsFrank Takkinen$12302.7% upsideOpen
2023-01-06Morgan Stanley$9.5218.8% upsideOpen
2022-12-12Wells Fargo$6101.3% upsideOpen
2022-12-12Citigroup$10235.6% upsideOpen
2022-07-18Stifel Nicolaus$20571.1% upsideOpen
2022-07-15Morgan Stanley$19537.6% upsideOpen

Pulmonx (LUNG) FAQ

Pulmonx (LUNG) currently reports a target price of $5. Use the charts on this page to explore Pulmonx's target price history and peer comparisons.

Analysts' average 12-month price target for Pulmonx is $5, about 67.8% upside from the current share price of $2.98. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $5, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pulmonx, and consider following LUNG for alerts when major investors trade the stock.

Pulmonx is classified in the Healthcare sector. On target price, it currently shows $5. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LUNG with unrelated industries.